Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes

Nanjing Medical University

Status: Completed

Conditions: Type2 Diabetes

Study type: Observational

Funder types: Other

Identifiers

NCT03362112

ENDO20171130-1

Details and patient eligibility

About

Lipoprotein-associated phospholipase A2 (LP-PLA2) is a good marker of cardiovascular risk and inflammation. This study aims at the characteristic and clinical significance of LP-PLA2 test in patients with type 2 diabetes(T2D).

Full description

The investigators recorded clinical factors, serum levels of glucose, HbA1c, lipids and LP-PLA2 in patients with T2D who visited in the Department of Endocrinology at the Nanjing First Hospital from January 2015 to August 2016. The relationship between levels of LP-PLA2 and diabetic complications are analysed.

Enrollment: 1,713 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with T2D and the diagnostic criteria of T2D is according to the World Health Organization in 1999.

Exclusion criteria

1. Patients use systemic steroidal anti-inflammatory drugs.
2. Patients are pregnant.
3. Patients with an acute infection.